3 recruiting, 2 active not recruiting, 1 unknown. 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
| Not applicable | 1 | Recruiting 1 |
Follow PSMA PET: new trials by email Literature Review of PSMA PET trials Research Report on PSMA PET
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis Prostate Cancer (Diagnosis), Bone Metastasis | Recruiting | Xijing Hospital | 1000 | 2026-03-12 | 2026-04-28 | |
| PSMA PET Combined With MRI for the Detection of PCa 68Ga-PSMA-11 - PCA, Prostate Cancer | Phase 3 | Active not recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 338 | 2025-08-18 | 2026-10-20 |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine - Prostate Cancer, 18F- Fluorocholine | Phase 3 | Unknown | ITEL Telecomunicazioni Srl | 106 | 2022-12-19 | 2024-05-22 |
| 68Ga-PSMA PET in the Renal Cell Carcinoma PSMA PET - Renal Cancer, Metastases | Not applicable | Recruiting | Xijing Hospital | 300 | 2021-06-01 | 2026-03-11 |
| Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer High-risk Prostate Cancer, PSMA PET | Recruiting | Xijing Hospital | 110 | 2021-03-07 | 2026-04-28 | |
| Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study PSMA PET - Prostate Cancer, High Risk Prostate Cancer | Active not recruiting | General University Hospital, Prague | 400 | 2016-01-01 | 2026-05-27 |
Prostatic Neoplasms (5) · Disease (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1)
Male Urogenital Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Genital Diseases (5) · Genital Diseases, Male (5) · Genital Neoplasms, Male (5) · Prostatic Diseases (5) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Neoplastic Processes (1)
18F-JK-PSMA-7 (1) · fluorocholine (1) · gallium 68 PSMA-11 (1)
Xijing Hospital (3) · General University Hospital, Prague (1) · ITEL Telecomunicazioni Srl (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1)
China (3) · Australia (1) · Italy (1) · United States (1)
PMID 15840561, PMID 20800404, PMID 21350618, PMID 21844889, PMID 23559588, PMID 23797218, PMID 24072344, PMID 24207135, PMID 24920079, PMID 25203127, PMID 25411132, PMID 25447835, PMID 27363387, PMID 28518227, PMID 30027419, PMID 30174470, PMID 30389823, PMID 30448957, PMID 30507748, PMID 31324713, PMID 31516367, PMID 31836681, PMID 31836682, PMID 34895925